Pan-Lin Capital, formally known as Shanghai Pan-Lin Asset Management Co., is a private equity firm based in Shanghai that specializes in asset management, particularly in equity investments and post-investment activities. The firm is registered with the China Securities Investment Fund Association and has successfully initiated and managed multiple private equity funds, including those focused on healthcare and environmentally-friendly industries. With a strong emphasis on professionalism and value creation, Pan-Lin Capital is supported by a skilled investment management team that possesses complementary expertise and extensive industrial resources. The firm is recognized for its successful exit cases and is positioned among the leaders in the RMB private equity fund market, with a focus on venture investments in healthcare, technology, and education sectors across China.
Zhishan Weixin Biotechnology integrates gene-drug research and development to treat genetic and neurodegenerative diseases. The company focuses on the research and development and subversive production of rAAV gene drugs. Zhishan Weixin's therapeutic areas cover blood diseases, rare diseases, and other disease areas.
NuProbe, Inc. is an early-stage molecular diagnostics company that focuses on noninvasive nucleic acid profiling and diagnostics. Founded in 2016 and based in Cambridge, Massachusetts, with an additional office in Shanghai, China, the company has developed a unique platform utilizing genetic toehold probes for quantitative PCR (qPCR) mutation detection. This innovative probe technology offers a Sample-In Answer-Out (SIAO) solution that integrates cell-free DNA extraction, qPCR analysis, sequencing, and bioinformatics interpretations, streamlining the diagnostic process.
Yueer is a genomics company driven by technology, with a number of revolutionary molecular detection technologies that can reduce the sequencing cost of all NGS platforms and the sensitivity of qPCR, Sanger, and nanopore sequencing. Yueer Gene collaborates with many partners to develop affordable, timely, and accurate genetic analysis tools in order to achieve precision medicine and improve patient outcomes.
PPIO is a distributed cloud computing company that provides decentralized distributed cloud services. The company's cloud computing platform is built on edge infrastructure based on the core and edge computing capabilities of cloud computing technology, forming an elastic cloud platform with comprehensive computing, network, storage, and security capabilities at the edge. PPIO's mission is to gather global computing resources and provide services for all mankind. It was founded in 2018 by Yao Xin and Wang Wenyu.
GenFleet Therapeutics, based in Shanghai, China, is a biotechnology company focused on the research and development of therapeutic molecules aimed at cancer treatment. Founded in 2017, the company specializes in creating innovative pharmaceuticals and antibody drugs that target various cancer systems. Its efforts are directed at reactivating tumor-specific immune responses and mobilizing the body's own immune system to combat cancer. GenFleet Therapeutics serves both domestic and international markets, contributing to advancements in cancer therapy through its development of signal transduction regulators, tumor microenvironment modulators, and transcription factors.
Xiaoxiang Zhihe is a packaging innovation Internet service platform from design to production. Xiaoxiang Zhihe focuses on professional packaging innovation, providing brands with product strategy, packaging creative design and structure development, brand color consistency management, sample production, packaging and printing production management and other services. Xiaoxiang Zhihe is committed to recreating an industrial Internet platform in China’s printing and packaging industry to centralize and online decentralized production capacity. At present, the company’s self-developed packaging and printing supply chain management platform connects more than 40 excellent design institutions and The 200 member factories provide a more convenient design innovation, flexible manufacturing, high-efficiency and high-quality intelligent supply chain service platform for the packaging upgrade of Chinese brands.
Xiaoxiang Zhihe is a packaging innovation Internet service platform from design to production. Xiaoxiang Zhihe focuses on professional packaging innovation, providing brands with product strategy, packaging creative design and structure development, brand color consistency management, sample production, packaging and printing production management and other services. Xiaoxiang Zhihe is committed to recreating an industrial Internet platform in China’s printing and packaging industry to centralize and online decentralized production capacity. At present, the company’s self-developed packaging and printing supply chain management platform connects more than 40 excellent design institutions and The 200 member factories provide a more convenient design innovation, flexible manufacturing, high-efficiency and high-quality intelligent supply chain service platform for the packaging upgrade of Chinese brands.
PPIO is a distributed cloud computing company that provides decentralized distributed cloud services. The company's cloud computing platform is built on edge infrastructure based on the core and edge computing capabilities of cloud computing technology, forming an elastic cloud platform with comprehensive computing, network, storage, and security capabilities at the edge. PPIO's mission is to gather global computing resources and provide services for all mankind. It was founded in 2018 by Yao Xin and Wang Wenyu.
KingstronBio specializes in the development and manufacturing of advanced heart valve products for cardiac surgeries. The company offers a comprehensive range of biological heart valves, focusing on minimally invasive solutions that enhance patient outcomes. Utilizing cutting-edge technologies, including anti-calcification, dry presentation, and leaflet thinning, KingstronBio aims to deliver innovative and effective products to the medical community, thereby addressing critical needs in cardiovascular care.
Provider of a clod chain logistics service platform in China intended to build a cold chain collaboration network. The company's platform links industry resources and customer demand with digital intelligence, enabling enterprises in the cold chain to optimize operational efficiency and reduce logistics costs.
NuProbe, Inc. is an early-stage molecular diagnostics company that focuses on noninvasive nucleic acid profiling and diagnostics. Founded in 2016 and based in Cambridge, Massachusetts, with an additional office in Shanghai, China, the company has developed a unique platform utilizing genetic toehold probes for quantitative PCR (qPCR) mutation detection. This innovative probe technology offers a Sample-In Answer-Out (SIAO) solution that integrates cell-free DNA extraction, qPCR analysis, sequencing, and bioinformatics interpretations, streamlining the diagnostic process.
GenFleet Therapeutics, based in Shanghai, China, is a biotechnology company focused on the research and development of therapeutic molecules aimed at cancer treatment. Founded in 2017, the company specializes in creating innovative pharmaceuticals and antibody drugs that target various cancer systems. Its efforts are directed at reactivating tumor-specific immune responses and mobilizing the body's own immune system to combat cancer. GenFleet Therapeutics serves both domestic and international markets, contributing to advancements in cancer therapy through its development of signal transduction regulators, tumor microenvironment modulators, and transcription factors.
Virogin Biotech Ltd., founded in 2015 and based in Vancouver, Canada, focuses on developing innovative oncolytic virus therapeutics aimed at treating cancer. Utilizing its proprietary Synerlytic™ technical platform, the company enhances cancer treatment by harnessing immunological principles to create therapies that stimulate and amplify the body's immune response against tumors. Virogin's approach is centered on leveraging multiple payload expressions to generate a robust and transient antiviral immune response, thereby improving systemic antitumor immunity. With its commitment to advancing immunotherapy, Virogin aims to establish itself as a leader in the field of immuno-oncology.
Virogin Biotech Ltd., founded in 2015 and based in Vancouver, Canada, focuses on developing innovative oncolytic virus therapeutics aimed at treating cancer. Utilizing its proprietary Synerlytic™ technical platform, the company enhances cancer treatment by harnessing immunological principles to create therapies that stimulate and amplify the body's immune response against tumors. Virogin's approach is centered on leveraging multiple payload expressions to generate a robust and transient antiviral immune response, thereby improving systemic antitumor immunity. With its commitment to advancing immunotherapy, Virogin aims to establish itself as a leader in the field of immuno-oncology.
GenFleet Therapeutics, based in Shanghai, China, is a biotechnology company focused on the research and development of therapeutic molecules aimed at cancer treatment. Founded in 2017, the company specializes in creating innovative pharmaceuticals and antibody drugs that target various cancer systems. Its efforts are directed at reactivating tumor-specific immune responses and mobilizing the body's own immune system to combat cancer. GenFleet Therapeutics serves both domestic and international markets, contributing to advancements in cancer therapy through its development of signal transduction regulators, tumor microenvironment modulators, and transcription factors.
Shanghai Percipio Information Technology Co., Ltd. is a technology company that specializes in 3D machine vision technology, focusing on the development and manufacturing of 3D-depth cameras and supporting software. Established in 2015 and based in Shanghai, the company provides integrated hardware and algorithms tailored for various sectors, including manufacturing, logistics, smart security, and healthcare. Its products are utilized for applications such as industrial automation, quality control, and robot vision, enabling clients to enhance operational efficiency through advanced analytics and visual capabilities. Percipio's solutions cater to industries like automotive, public transit, and entertainment, positioning the company as a key player in the 3D vision technology market.
Suzhou Ribo Life Science is a developer of RNA interference ( RNAi ) technology designed to treat liver diseases. The company's RNA interference ( RNAi ) technology is used to develop nucleic acid therapeutic drugs and related products, enabling healthcare providers to deliver more effective pharmaceuticals to patients.
Yesmro is a self-operated e-commerce of MRO industrial consumer goods.
Antekang Cheng
Seed Round in 2019
Antai Kangcheng is a research and development company for tumor electric field treatment technology, focusing on the development of innovative tumor treatment methods, equipment and equipment for central nervous system injury repair and rehabilitation. Antai Kangcheng has also established a precise and optimized treatment planning system based on biophysical models and multimodal imaging systems, and is committed to developing a personalized tumor electric field treatment system suitable for Chinese patients.
Happy Cycle
Seed Round in 2019
Happy Cycle is a fitness studio brand based on the dynamic cycling category. Based on the concept of “Make Fitness Having a Better Life”, Happy Cycle offers immersive fitness scenes and dynamic cycling verticals with music, games, video, social and other entertainment elements, allowing users to complete their fitness in the entertainment experience.
Qinheli Biomedical
Seed Round in 2019
Qinheli Biomedical is a tumor micro-environment-responsive drug developer dedicated to the development and production of low-toxic and highly effective patented anti-cancer drugs.
Shanghai Chuantu Microelectronics Co., Ltd. specializes in the design of semiconductor chips, focusing on radiofrequency analog chips and micromodules, along with related solutions. Established in 2016, the company is headquartered in Shanghai, China. Through its innovative chip designs, Chuantu Microelectronics aims to meet the growing demands of various industries that require advanced electronic components.
LangRui Medical
Seed Round in 2019
LangRui Medical is a cardiac remote diagnosis service provider, which provides users with cardiac medical remote diagnosis, data analysis, data storage and other services, and uses its own network platform to move the ECG inspection project of the networked top three hospitals to the primary medical institutions. Hospital medical informatization level.
Apollomics is a developer of oncology therapeutics intend to harness the immune system and targeting specific molecular pathways.The company's therapeutics target the growth and proliferation of cancer cells and offer an oral c-Met inhibitor that restores the body's immune system to recognize and kill cancer cells, enabling clients to treat their patients in an enhanced way.
Gongguizhijia is a Shanghai-based company that specializes in providing a technology service platform for commercial vehicles. Established in 2014, it offers comprehensive support services primarily for after-sales maintenance service stations and aftermarket customers in the commercial vehicle sector. The company aims to enhance the efficiency and effectiveness of vehicle maintenance through its innovative solutions, catering to the needs of various stakeholders within the transportation industry.
IRiS Technology (China) is a provider of business intelligence IT services focused on the automotive retail sector. The company offers integrated retail information solutions that automate management processes for vehicle retailers. Its services encompass cloud-based data storage and analysis, mobile application development, and corporate management consulting. By delivering personalized solutions, IRiS Technology aims to assist car dealers and manufacturers in enhancing their operational efficiency and increasing revenue.
Shanghai Chuantu Microelectronics Co., Ltd. specializes in the design of semiconductor chips, focusing on radiofrequency analog chips and micromodules, along with related solutions. Established in 2016, the company is headquartered in Shanghai, China. Through its innovative chip designs, Chuantu Microelectronics aims to meet the growing demands of various industries that require advanced electronic components.
Chengdu XGimi Technology Co., Ltd. is a manufacturer based in Chengdu, China, specializing in high-performance smart projectors and laser TVs. Established in 2012, the company develops a range of products, including the XGIMI MoGo, XGIMI MoGo Pro, XGIMI Halo, and XGIMI H2 Global Version SCREENLESS TV, along with various accessories. XGimi's projectors are designed to offer high-definition viewing experiences and are often equipped with features such as embedded Android operating systems and three-dimensional viewing capabilities. The company's mission focuses on creating accessible and innovative giant-screen projection solutions for consumers worldwide.
Shanghai Ensenmax Co., Ltd. is engaged in industrial gas intelligent monitoring and Internet of Things solutions. The firm was founded in 2016 and is headquartered in Shanghai, China.
YCloset was an online platform based in Beijing that offered a clothing rental and shopping service specifically for women. Founded in 2015, the platform allowed users to enroll for a monthly fee, enabling them to rent clothes and accessories without additional charges for individual items. YCloset operated in approximately 40 cities across China, including major urban centers like Beijing, Shanghai, Guangzhou, and Shenzhen. The company partnered with over a hundred fashion brands to provide a diverse selection of rental options, helping women stay current with fashion trends without the need to purchase new clothing. However, YCloset announced its closure, ceasing operations by August 15, 2021.
Suzhou Ribo Life Science is a developer of RNA interference ( RNAi ) technology designed to treat liver diseases. The company's RNA interference ( RNAi ) technology is used to develop nucleic acid therapeutic drugs and related products, enabling healthcare providers to deliver more effective pharmaceuticals to patients.
Beijing Percans Oncology Research Co., Ltd. is a medical service provider focused on delivering personalized treatment plans for cancer patients. Based in Beijing, China, the company specializes in developing innovative cancer-specific drug products, particularly in the areas of synthetic lethality and immunotherapy. By tailoring treatment strategies to the unique needs of each patient, Percans Oncology aims to enhance the effectiveness of cancer therapies, ultimately helping to extend and improve patients' lives.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.